[Cut-off level of docetaxel, paclitaxel and gemcitabine in histoculture drug response assay for non-small cell lung cancer].
Gan To Kagaku Ryoho
; 32(7): 1013-6, 2005 Jul.
Article
em Ja
| MEDLINE
| ID: mdl-16044964
ABSTRACT
Cut-off levels of docetaxel (DOC), paclitaxel (PAC), and gemcitabine (GEM) in histoculture drug response assay are determined by data acquisition of non-small cell lung cancer. Inhibition rates were 47.5 +/- 22.2% in DOC (n=181), 66.6 +/- 25.1% in PAC (n=57), and 25.4 +/- 18.4% in GEM (n=63), respectively. Cut-off levels were determined as 50% in DOC, 60% in PAC, and 30% in GEM. The positive rates such as 47.5% in DOC, 68.4% in PAC, and 33.3% in GEM were obtained.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Paclitaxel
/
Carcinoma Pulmonar de Células não Pequenas
/
Taxoides
/
Desoxicitidina
/
Neoplasias Pulmonares
/
Antineoplásicos Fitogênicos
Idioma:
Ja
Ano de publicação:
2005
Tipo de documento:
Article